[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100602980":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":59,"collaborators":63,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":10,"eligibilityCriteria":70,"healthyVolunteers":71,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":78,"studyType":79,"phases":10,"briefSummary":80,"conditions":81,"keywords":85,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Tianjin Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Group Assignment",null,"Each subject receive a single intravenous injection of 18F-92\u002FAV45\u002FTPZA\u002FFT8, 11CPIB and undergo PET\u002FCT or MRI imaging within the specificed time.",[13],"Diagnostic Test: 18F-92\u002FAV45\u002FTPZA\u002FFT8, 11CPIB",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","18F-92\u002FAV45\u002FTPZA\u002FFT8, 11CPIB","Each subject receive a single intravenous injection of 18F-92\u002FAV45\u002FTPZA\u002FFT8, 11C-PIB and undergo PET\u002FCT or MRI imaging within the specificed time.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Haonan Yu, MD","CONTACT","+8613821000597","dreamadam@126.com",[27,46],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"The First Affiliated Hospital of University of Science and Technology of China","RECRUITING","Hefei","Anhui","230000","China","CN",{"type":36,"coordinates":37},"Point",[38,39],117.28083,31.86389,{"lat":39,"lon":38},[42],{"name":43,"role":23,"phone":44,"phoneExt":10,"email":45},"Qiang Xie, PhD","+8613721108043","ahxq1980@163.com",{"facility":47,"status":29,"city":48,"state":49,"zip":50,"country":33,"countryCode":34,"cosmosGeoPoint":51,"geoPoint":55,"contacts":56},"Tianjin Medical University General Hospital","Tianjin","Tianjin Municipality","350005",{"type":36,"coordinates":52},[53,54],117.17667,39.14222,{"lat":54,"lon":53},[57],{"name":22,"role":23,"phone":58,"phoneExt":10,"email":25},"+862260362190",{"type":60,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Shaobo Yao, PhD","Prof.",[64],{"name":47,"class":6},"100602980","pan-amyloid-petct-in-various-amyloid-related-disease-100602980",false,"NCT07130565","Pan-Amyloid PET\u002FCT in Various Amyloid-Related Disease","Inclusion Criteria:\n\n\\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated cardiac amyloidosis (supporting evidence may include MRI, CT, serum markers and pathology report); (iii) patients who had scheduled Pan-Amyloid PET\u002FCT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.\n\nExclusion Criteria:\n\n\\- (i) patients with non-CA lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.",true,"ALL","18 Years","80 Years",{"count":76,"type":77},500,"ESTIMATED","7 Days","OBSERVATIONAL","To evaluate the potential usefulness of 18F-92\u002FAV45\u002FTPZA\u002FFT8, 11C-PIB positron emission tomography\u002Fcomputed tomography (PET\u002FCT) for the diagnosis of primary and metastatic lesions in various Pan-Amyloid-related disease patients.",[82,83,84],"Amyloid","Cardiac Amyloidosis","Amyloidosis",[86,87,88],"PET\u002FCT","MRI","Pan-Amyloid","2025-08-12",{"date":91,"type":92},"2025-08-19","ACTUAL",{"date":94,"type":92},"2023-11-01",{"date":96,"type":77},"2028-11-01",{"name":5,"class":6},2]